| Title (priority date): |
| Reference: |
52574 |
| Inventors: |
Hynes & Schlange |
| Description: |
This patent application is based on the findings that Frizzled-1 and/or Frizzled-4 are over-expressed in cancer. |
| Applications: |
Cancer treatments and/or biomarkers for e.g. diagnosis or patients stratification. |
| Status: |
Pending PCT |
| Opportunity: |
Exclusive and non exclusive license |
| Publications: |
Breast Cancer Res. 2009 May 27;11(3):R32 ;
Biochem Biophys Res Commun. 2009 Aug 28;386(3):449-54 |
| Contact: |
Dr. Nicolas Favre, tel: +41 61 6978382, e-mail: nicolas.favre@fmi.ch |
| PCT File: |
WO 2009/112448 |
